checkAd

     197  0 Kommentare Oncternal Therapeutics Announces its Prostate Cancer Scientific Advisory Board - Seite 4

    Contact Information:

    Investors
    Richard Vincent
    Chief Financial Officer
    858-434-1113
    rvincent@oncternal.com

    Lesen Sie auch

    Media
    Corey Davis, Ph.D.
    LifeSci Advisors
    212-915-2577
    cdavis@lifesciadvisors.com



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 4 von 4

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Oncternal Therapeutics Announces its Prostate Cancer Scientific Advisory Board - Seite 4 SAN DIEGO, Sept. 07, 2023 (GLOBE NEWSWIRE) - Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced the establishment of its Prostate Cancer …